Authors

• Kimia Kamelian (ORCID: https://orcid.org/0000-0003-3465-1285)
• Enti Spata (ORCID: https://orcid.org/0000-0002-7207-2076)
• L. Fong
• David M. Favara (ORCID: https://orcid.org/0000-0003-3189-6658)
• James Morris (ORCID: https://orcid.org/0000-0002-5040-9483)
• Ravindra K. Gupta (ORCID: https://orcid.org/0000-0001-9751-1808)
• Mark T. K. Cheng (ORCID: https://orcid.org/0000-0003-4323-5574)
• Aparna Irodi (ORCID: https://orcid.org/0000-0002-6587-998X)
• Abraham Tolley (ORCID: https://orcid.org/0000-0002-4739-4575)
• Margaret Kay Ho (ORCID: https://orcid.org/0000-0002-4809-091X)
• Shahruq R. Sarela
• Abdulbasit O Fehintola
• A. L. Burn
• Syed Fazal Hussein Shah (ORCID: https://orcid.org/0000-0003-0624-1246)
• Muhammad Hasan
• Benjamín L. Sievers (ORCID: https://orcid.org/0000-0002-9681-9082)
• José Chen-Xu (ORCID: https://orcid.org/0000-0003-1238-1384)
• Nihal Sogandji (ORCID: https://orcid.org/0000-0001-6982-8672)
• Anita Patel (ORCID: https://orcid.org/0009-0000-6433-1771)
• Chengqiang Yin (ORCID: https://orcid.org/0000-0002-0658-3222)
• J. Chan (ORCID: https://orcid.org/0000-0002-2151-8031)
• Ghislaine D Mbolo

Institutions

• University of Leeds (GB)
• University of Lisbon (PT)
• University of Liverpool (GB)
• MRC Laboratory of Molecular Biology (GB)
• University of Ibadan (NG)
• University of Cambridge (GB)
• Queen Mary Hospital (CN)
• Cambridge University Hospitals NHS Foundation Trust (GB)
• John Radcliffe Hospital (GB)
• University of Oxford (GB)
• AstraZeneca (Singapore) (SG)
• Celulose Beira Industrial (Portugal) (PT)
• University College London (GB)
• Universidade Nova de Lisboa (PT)
• University of Hong Kong (HK)
• London School of Economics and Political Science (GB)

Publication Details

Journal

EClinicalMedicine

Published

2025-05-01

DOI

https://doi.org/10.1016/j.eclinm.2025.103194

Citations

1

Primary Topic

COVID-19 and healthcare impacts

Type

article

Field-Weighted Citation Impact

1.05

Funders

• UK Research and Innovation
• Cancer Research UK
• Medical Research Council